Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 10 June 2019. Cisco Vicenty.

Executive Summary

The FDA wants to spur medical device innovation and production in the US with its new "Bring MedTech Manufacturing Home" initiative – and the agency already has a leg up on that goal with its ongoing Case for Quality Voluntary Improvement Program (CFQ VIP) that measures device-makers' manufacturing maturity and quality. See what the FDA's Cisco Vicenty said about it here.

"The Case for Quality VIP initiative is part of what's under that [Bring MedTech Manufacturing Home] umbrella for establishing a third-party mechanism – one that will allow us to use a lot of what we've already put into practice, and make that a sustained and operational operation and mode for future activities." – Cisco Vicenty, Case for Quality program manager, US FDA

Click here for a free trial of Medtech Insight


Related Content

Make America Manufacture Again? FDA Incentivizing 'Smart Manufacturing Solutions' To Shift Device-Making To US





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts